Clinical Trial: Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561801) titled 'Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit' on April 25.

Brief Summary: The aim of this study is to evaluate the effect of pentoxifylline for control of contrast induced nephropathy in chronic kidney diseased patients in intensive care unit.

Study Start Date: July 01, 2024

Study Type: INTERVENTIONAL

Condition: Pentoxifylline Contrast Induced Nephropathy Chronic Kidney Disease Intensive Care Unit

Intervention: DRUG: Pentoxifylline

Patients received hydration (100ml normal saline every hour (2400ml/day) with closed dynamic monitoring of the blood volume...